MT1M: A Protein Implicated in T Cell Development (G4499)

Target Name: MT1M

NCBI ID: G4499

MT1M: A Protein Implicated in T Cell Development

MT1M, also known as Metallothionein 1Y, is a protein that is expressed in a variety of tissues throughout the body. It is a member of the thymus family, which includes proteins that play a critical role in the development and maintenance of the thymus gland.

The thymus gland is a vital organ that is responsible for the development and maturation of T cells, which are a crucial part of the immune system. T cells are responsible for recognizing and responding to foreign substances in the body, and they are an important part of the immune system.

MT1M is a protein that is expressed in the thymus gland, and it is believed to play a critical role in the development and maintenance of T cells. It is made up of four domains: an N-terminus, a C-terminus, a middle transmembrane region, and an optional C-terminal region.

The N-terminus of MT1M is a protein that is known as MTC1 (Metallothionein C1), and it is a key component of the thymus gland. MTC1 is a 21-kDa protein that is made up of 115 amino acids. It is located at the center of the thymus gland and is involved in the development and maintenance of T cells.

The C-terminus of MT1M is a protein that is known as MTC2 (Metallothionein C2), and it is also a key component of the thymus gland. MTC2 is a 19-kDa protein that is made up of 114 amino acids. It is located at the edge of the thymus gland and is involved in the development and maintenance of T cells.

The middle transmembrane region of MT1M is a region that is located between the N-terminus and the C-terminus. It is thought to play a critical role in the regulation of the movement of cells in the thymus gland.

The C-terminal region of MT1M is a region that is located at the end of the protein. It is not known to have any function in the thymus gland.

MT1M is a protein that is expressed in a variety of tissues throughout the body, including the thymus gland, the bone marrow, the spleen, and the lymph nodes. It is thought to play a critical role in the development and maintenance of T cells, which are a crucial part of the immune system.

Due to its involvement in the development and maintenance of T cells, MT1M is a potential drug target or biomarker. Researchers are currently working to develop methods for delivering MT1M directly to the thymus gland, with the goal of using it as a treatment for conditions such as thymus insufficiency and myelodysplastic syndromes.

In addition to its potential use as a drug, MT1M is also being studied as a biomarker for the diagnosis and prognosis of various diseases. For example, researchers have used MT1M as a marker for the diagnosis of acute myeloid leukemia, and they have found that higher levels of MT1M are associated with a more favorable prognosis.

Overall, MT1M is a protein that is expressed in the thymus gland and is involved in the development and maintenance of T cells. It is a potential drug target or biomarker, and researchers are currently working to develop methods for delivering MT1M directly to the thymus gland as a treatment for various diseases.

Protein Name: Metallothionein 1M

Functions: Metallothioneins have a high content of cysteine residues that bind various heavy metals; these proteins are transcriptionally regulated by both heavy metals and glucocorticoids

More Common Targets